\n<\/p>\n
The Global Continuous Glucose Monitoring (CGM) Sensors Market is valued at US$ 7.6 Bn in 2024 and is expected to reach US$ 19.9 Bn by 2034, with a CAGR of 10.2% during the forecast period of 2025-2034.<\/p>\n
Global Continuous Glucose Monitoring (CGM) Sensors Market 2025-2034 full Research Repot latest version is now available.<\/p>\n
Get Free Access to Demo Report, Excel Pivot and ToC: https:\/\/www.insightaceanalytic.com\/request-sample\/1181<\/a><\/p>\n Continuous Glucose Monitoring (CGM) sensors are advanced medical devices that continuously measure glucose levels in the interstitial fluid just beneath the skin, offering real-time data and trend insights for individuals, particularly those managing diabetes. <\/p>\n In contrast to conventional blood glucose meters that use fingerstick samples for single-point measurement, CGM sensors monitor fluctuations in glucose during the day and night with a small, minimally invasive sensor placed under the skin, a transmitter to transmit data, and a receiver or compatible smart device to show readings. <\/p>\n These sensors have become invaluable in diabetes care by allowing real-time monitoring to identify trends and fluctuations, providing warnings for high-risk glucose values, informing insulin dosing and food choices with detailed glucose profiles, and being incorporated into automated insulin delivery systems as part of the development of artificial pancreas technologies. <\/p>\n They accommodate personal and professional use, offering real-time or retrospective analysis of data. As the world has seen an increase in diabetes prevalence, CGM sensors are very important in enhancing glycemic control, lessening variability and complications, limiting the number of fingersticks, and enabling patients and healthcare professionals with useful information to make more informed treatment and lifestyle decisions. <\/p>\n List of Prominent Players in the Continuous Glucose Monitoring (CGM) Sensors Market:<\/p>\n \u0095\tMedtronics Continuous Glucose Monitoring (CGM) Sensors Market Report Scope: Expert Knowledge, Just a Click Away: https:\/\/calendly.com\/insightaceanalytic\/30min?month=2025-04<\/a><\/p>\n Market Dynamics: The movement towards preventive and personalized care also increases the uptake of CGM by allowing real-time, tailored monitoring. Improved accuracy and end-user experience due to advancements like minimally invasive sensors, integration with smartphones, and AI-powered analytics further promote CGM. Also, wider regulatory approvals, wider insurance coverage, and governmental programs are enlarging availability, driving market expansion. <\/p>\n Challenges: Regional Trends: Comprehensive insurance coverage and rising reimbursement policies further enable users to afford CGMs, while high patient and practitioner awareness has driven the transition from standard glucose meters to CGM systems.<\/p>\n Unlock Your GTM Strategy: https:\/\/www.insightaceanalytic.com\/customisation\/1181<\/a><\/p>\n Recent Developments: Segmentation of Continuous Glucose Monitoring (CGM) Sensors Market- Why should buy this report: Read Overview Report- https:\/\/www.insightaceanalytic.com\/report\/global-continuous-glucose-monitoring-cgm-sensors-market-\/1181<\/a><\/p>\n About Us: Contact us:
\n\u0095\tDexcom
\n\u0095\tSenseonics
\n\u0095\tWaveForm Technologies, Inc.
\n\u0095\tAbbott Diabetes Care Inc
\n\u0095\tArkal Medical, Inc.
\n\u0095\tAscensia Diabetes Care Holdings AG
\n\u0095\tBiorasis Inc
\n\u0095\tDebiotech SA
\n\u0095\tDirectSens GmbH
\n\u0095\tEcho Therapeutics Inc
\n\u0095\tEyeSense GmbH
\n\u0095\tFlowsion A\/S
\n\u0095\tGlucoSet AS
\n\u0095\tGlucovation Inc
\n\u0095\tGlusense Ltd
\n\u0095\tGlySens Inc
\n\u0095\tiGlyko, Inc.
\n\u0095\tIndigo Diabetes NV
\n\u0095\tInsulet Corp
\n\u0095\tIntegrated Medical Sensors
\n\u0095\tIntegrity Applications Ltd
\n\u0095\tI-Sens Inc
\n\u0095\tMetronom Health Inc
\n\u0095\tNemaura Medical Inc
\n\u0095\tPKvitality
\n\u0095\tPrediktor Medical AS
\n\u0095\tProfusa Inc
\n\u0095\tSan Meditech (Huzhou) Co., Ltd.
\n\u0095\tSenzime AB
\n\u0095\tSocrates Health Solutions, Inc.<\/p>\n
\nReport Attribute\tSpecifications
\nMarket Size Value In 2024\tUSD 7.6 Bn
\nMarket Size Value In 2034\tUSD 19.9 Bn
\nGrowth rate CAGR\tCAGR of 10.2% from 2025 to 2034
\nQuantitative units\tRepresentation of revenue in US$ Mn, and CAGR from 2025 to 2034
\nHistoric Year\t2021 to 2024
\nForecast Year\t2025-2034
\nReport coverage\tThe forecast of revenue, the position of the company, the competitive market statistics, growth prospects, and trends
\nSegments covered\tBy Sensor Type\/Technology, By End-Users, By Wear Time, By Application
\nRegional scope\tNorth America; Europe; Asia Pacific; Latin America; Middle East & Africa
\nCountry scope\tU.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; Southeast Asia<\/p>\n
\nDrivers-
\nThe increasing world-wide prevalence of diabetes, accountable for 3.4 million deaths in the year 2024, is fueling the CGM sensors market. As diabetes incidence increases, demand for continuous glucose monitoring solutions to enhance disease control is on the rise. <\/p>\n
\nThe market for CGM sensors is challenged by such issues as high expense, reduced availability, and variable insurance coverage, particularly among type 2 diabetes patients. Accuracy issues, especially at the start and end of wear, and inability to detect hypoglycemia result in patient dissatisfaction. Such technical problems as Bluetooth loss of connection and data transmission errors may cause missed readings, while sensor lag (5\u009620 minutes) and repeated calibration needs detract from convenience and user compliance. <\/p>\n
\nNorth America, particularly the United States, leads the global CGM sensors market, driven by a high prevalence of diabetes, with an estimated 38.4 million people affected in 2021. Advanced healthcare infrastructure within the region has facilitated the use of CGM technologies on a large scale. Continuous investment by leading companies in R&D has led to extremely accurate, easy-to-use, and affordable devices. <\/p>\n
\n\u0095\tIn April 2025, DexCom received FDA clearance for its G7 15-Day CGM system for U.S. adults, offering its longest-lasting and most accurate sensor yet (MARD 8.0%). Set to launch in the second half of the year, the approval strengthens DexCom’s leadership in CGM technology and promises improved diabetes management.
\n\u0095\tIn August 2024, Medtronic received FDA approval for its Simplera CGM, a smaller, all-in-one, disposable sensor requiring no overtape. Designed for Smart MDI use and future integration with the MiniMed 780G system, it simplifies use and boosts comfort, strengthening Medtronic\u0092s position in the CGM market. <\/p>\n
\nBy Sensor Type\/Technology:
\n\u0095\tReal-Time CGM Sensors
\n\u0095\tIntermittently Scanned CGM Sensors (Flash)
\n\u0095\tImplantable CGM Sensors
\n\u0095\tNon-Invasive CGM Sensors
\nBy Wear Time:
\n\u0095\tShort-Term Sensors (7-14 days)
\n\u0095\tLong-Term Sensors (180-365 days)
\n\u0095\tDaily Sensors (1-day)
\n\u0095\tOthers
\nBy Application:
\n\u0095\tHome Care\/Personal use
\n\u0095\tSpecialty Clinics
\n\u0095\tOthers
\nBy End-User:
\n\u0095\tConsumers (Home Use)
\n\u0095\tAthletes\/Fitness Enthusiasts
\n\u0095\tElderly Population
\n\u0095\tHealthcare Providers
\nBy Region-
\nNorth America-
\n\u0095\tThe US
\n\u0095\tCanada
\nEurope-
\n\u0095\tGermany
\n\u0095\tThe UK
\n\u0095\tFrance
\n\u0095\tItaly
\n\u0095\tSpain
\n\u0095\tRest of Europe
\nAsia-Pacific-
\n\u0095\tChina
\n\u0095\tJapan
\n\u0095\tIndia
\n\u0095\tSouth Korea
\n\u0095\tSouth East Asia
\n\u0095\tRest of Asia Pacific
\nLatin America-
\n\u0095\tBrazil
\n\u0095\tArgentina
\n\u0095\tMexico
\n\u0095\tRest of Latin America
\n Middle East & Africa-
\n\u0095\tGCC Countries
\n\u0095\tSouth Africa
\n\u0095\tRest of Middle East and Africa<\/p>\n
\n\uf0d8\tTo receive a comprehensive analysis of the prospects for global Continuous Glucose Monitoring (CGM) Sensors Market
\n\uf0d8\tTo receive industry overview and future trends of global Continuous Glucose Monitoring (CGM) Sensors Market
\n\uf0d8\tTo analyze the Continuous Glucose Monitoring (CGM) Sensors Market drivers and challenges
\n\uf0d8\tTo get information on the Continuous Glucose Monitoring (CGM) Sensors Market size value (US$ Mn) forecast till 2034
\n\uf0d8\tMajor Investments, Mergers & Acquisition in global AI\/ML and Computational Tools in RNA Research and Therapeutics industry<\/p>\n
\nInsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.<\/p>\n
\nInsightAce Analytic Pvt. Ltd.
\nVisit: www.insightaceanalytic.com<\/a>
\nTel : +1 551 226 6109
\nAsia: +91 79 72967118
\ninfo@insightaceanalytic.com <\/p>\n<\/div>\n